Insider: Yale Catriona Chief Development Officer - Akero Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 90,829 | 0 | 90,829 |
| Value | $4,268,054.71 | $0.00 | $4,268,054.71 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/11/2025 | DDS | 659 | Direct | COM | $43.02 | $28,350.18 | 90,829 |
| 07/16/2025 | DDS | 8,658 | Direct | COM | $52.87 | $457,705.17 | 92,830 |
| 07/16/2025 | DDS | 1,342 | Direct | COM | $53.47 | $71,762.11 | 91,488 |
| 06/18/2025 | DDS | 1,633 | Direct | COM | $54.84 | $89,553.72 | 90,598 |
| 06/16/2025 | DDS | 6,210 | Direct | COM | $53.78 | $333,973.80 | 96,021 |
| 06/16/2025 | DDS | 2,895 | Direct | COM | $54.80 | $158,643.11 | 93,126 |
| 06/16/2025 | DDS | 895 | Direct | COM | $55.52 | $49,689.51 | 92,231 |
| 06/10/2025 | DDS | 2,803 | Direct | COM | $54.00 | $151,350.79 | 92,231 |
| 05/15/2025 | DDS | 4,384 | Direct | COM | $39.91 | $174,947.90 | 95,034 |
| 05/15/2025 | DDS | 2,837 | Direct | COM | $38.20 | $108,370.56 | 102,197 |
| 05/15/2025 | DDS | 2,779 | Direct | COM | $39.46 | $109,659.34 | 99,418 |
| 04/15/2025 | DDS | 7,873 | Direct | COM | $37.80 | $297,623.02 | 96,234 |
| 04/15/2025 | DDS | 1,200 | Direct | COM | $38.62 | $46,339.20 | 95,034 |
| 03/17/2025 | DDS | 1,799 | Direct | COM | $45.05 | $81,044.95 | 95,034 |
| 03/17/2025 | DDS | 8,201 | Direct | COM | $44.70 | $366,560.10 | 96,833 |
| 03/12/2025 | DDS | 614 | Direct | COM | $44.88 | $27,556.32 | 95,034 |
| 02/18/2025 | DDS | 9,100 | Direct | COM | $49.79 | $453,089.00 | 96,548 |
| 02/18/2025 | DDS | 900 | Direct | COM | $50.63 | $45,570.60 | 95,648 |
| 01/27/2025 | DDS | 17,000 | Direct | COM | $55.16 | $937,652.00 | 132,238 |
| 01/27/2025 | DDS | 9,250 | Direct | COM | $55.95 | $517,528.25 | 122,988 |
| 01/27/2025 | DDS | 27,340 | Direct | COM | $57.02 | $1,559,036.16 | 95,648 |
| 01/27/2025 | DDS | 8,700 | Direct | COM | $57.01 | $495,960.90 | 95,648 |
| 01/27/2025 | DDS | 14,467 | Direct | COM | $55.95 | $809,428.65 | 104,348 |
| 01/27/2025 | DDS | 25,907 | Direct | COM | $55.15 | $1,428,822.86 | 118,815 |
| 12/16/2024 | DDS | 9,074 | Direct | COM | $29.11 | $264,116.92 | 95,648 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research